ArticleVaccines2022

Development and Testing of a Low-Cost Inactivation Buffer That Allows for Direct SARS-CoV-2 Detection in Saliva.

Brandon Bustos-Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.